AC699

Asset

Degrades the estrogen receptor.

Stage
Phase 1
Modality
Not known
Target
ESR1
1
Indication
0
Trials
1
Developer

Indications

1
  • ER-positive/HER2-negative advanced or metastatic breast cancer

    Phase 1, accutarbio.com, 10 Oct 2026

In the full profile

  • Targets and what it contains1
  • Owner and partners1
  • Evidence for its targets1
  • Competitors12

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets